0001209191-23-007770.txt : 20230208
0001209191-23-007770.hdr.sgml : 20230208
20230208160526
ACCESSION NUMBER: 0001209191-23-007770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230206
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Joseph R
CENTRAL INDEX KEY: 0001861684
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 23599065
MAIL ADDRESS:
STREET 1: C/O VERA THERAPEUTICS, INC.
STREET 2: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-06
0
0001831828
Vera Therapeutics, Inc.
VERA
0001861684
Young Joseph R
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE
CA
94005
0
1
0
0
SVP, Finance, Chief Acct Offcr
Class A Common Stock
2022-02-06
4
P
0
5714
7.00
A
22679
D
Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023. The purchase price is the offering price.
Includes 817 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022.
/s/ Joseph R. Young
2023-02-08